AFTER THE INITIAL WEAKNESS IN THE MARKET ENTERED THE CONSOLIDATION PHASE AFTER REGISTERING THE MARGINAL GAINS JUST BEFORE CLOSING ON GOOD EUROPEAN CUES.NIFTY ENDED AT 5532 UP 15 POINTS & SENSEX ENDED AT 18420 UP 44 POINTS.
ANALYSTS BELIEVE THAT THEY ARE NOT CONVINCED GOING WITH THE EQUITIES. ACCORDING TO THEM POSITION IN THE MARKET SIGNALS THAT RETAILS INVESTORS HAVE LOW PARTICIPATION AND FIIs HAVE NOT MUCH POSITION BUILD-UP FOR THE MARKET TO CRASH.
THE POTENTIAL DOWN RISKS IN THE SHORT TERM: PROBABLY THE EURO COLLAPSE IN ONE OF THE EUROPEAN COUNTRIES MAY SPARK-OFF A SELL-OFF, DRAWING MONEY AWAY FROM THE EMERGING MARKETS,BARRING THIS MARKETS WILL CONTINUE TO DRAG DEPRESSINGLY WITH NO MAJOR MOVEMENT ON EITHER UPSIDE OR DOWN SIDE.HENCE GOING FORWARD A DEFENSIVE PORTFOLIO IS REQUIRED IN WHICH FMCG SHOULD BE GIVEN MORE WEIGHT RATHER THAN PHARMA STOCKS AS THE LATER HAS ALREADY SEEN A GOOD RUN IN THE PAST.
LONG POSITION COULD BE INITIATED ON ANY FALL AROUND 5450 WITH STRICT STOP LOSS AT 5380 FOR A VERY SHORT TERM TARGET OF 5620-5650 AN HIGHER TO 5700-5730.
FOLLOWING STOCKS SHOULD BE CONSIDERED IN THE PORTFOLIO:
INDIAN HOTELS
EIH
ITC
PATNI
INGERSOLL-RAND
SKUMAR
ARVIND
HOUSE OF PEARLS
PRAKASH IND
GITANJALI GEMS
GARDEN SILK
SURYA ROSHINI
Safe Harbor Statement:
Some forward looking statements on projections, estimates, expectations & outlook are included to enable a better comprehension of the Company prospects. Actual results may, however, differ materially from those stated on account of factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Company conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.Nothing in this article is, or should be construed as, investment advice.
Disclaimer:
This is neither an offer nor a solicitation to purchase or sell securities. The information and views contained on this blog are believed to be reliable, but no responsibility (or liability) is accepted for errors of fact or opinion. Writers and contributors may be trading in, or have positions in the securities mentioned in their articles. Neither I (Vikas Srivastava) nor any of the contributors accepts any liability arising out of use of the above information/article. Reproduction in whole or in part without written permission is prohibited.
ANALYSTS BELIEVE THAT THEY ARE NOT CONVINCED GOING WITH THE EQUITIES. ACCORDING TO THEM POSITION IN THE MARKET SIGNALS THAT RETAILS INVESTORS HAVE LOW PARTICIPATION AND FIIs HAVE NOT MUCH POSITION BUILD-UP FOR THE MARKET TO CRASH.
THE POTENTIAL DOWN RISKS IN THE SHORT TERM: PROBABLY THE EURO COLLAPSE IN ONE OF THE EUROPEAN COUNTRIES MAY SPARK-OFF A SELL-OFF, DRAWING MONEY AWAY FROM THE EMERGING MARKETS,BARRING THIS MARKETS WILL CONTINUE TO DRAG DEPRESSINGLY WITH NO MAJOR MOVEMENT ON EITHER UPSIDE OR DOWN SIDE.HENCE GOING FORWARD A DEFENSIVE PORTFOLIO IS REQUIRED IN WHICH FMCG SHOULD BE GIVEN MORE WEIGHT RATHER THAN PHARMA STOCKS AS THE LATER HAS ALREADY SEEN A GOOD RUN IN THE PAST.
LONG POSITION COULD BE INITIATED ON ANY FALL AROUND 5450 WITH STRICT STOP LOSS AT 5380 FOR A VERY SHORT TERM TARGET OF 5620-5650 AN HIGHER TO 5700-5730.
FOLLOWING STOCKS SHOULD BE CONSIDERED IN THE PORTFOLIO:
INDIAN HOTELS
EIH
ITC
PATNI
INGERSOLL-RAND
SKUMAR
ARVIND
HOUSE OF PEARLS
PRAKASH IND
GITANJALI GEMS
GARDEN SILK
SURYA ROSHINI
Safe Harbor Statement:
Some forward looking statements on projections, estimates, expectations & outlook are included to enable a better comprehension of the Company prospects. Actual results may, however, differ materially from those stated on account of factors such as changes in government regulations, tax regimes, economic developments within India and the countries within which the Company conducts its business, exchange rate and interest rate movements, impact of competing products and their pricing, product demand and supply constraints.Nothing in this article is, or should be construed as, investment advice.
Disclaimer:
This is neither an offer nor a solicitation to purchase or sell securities. The information and views contained on this blog are believed to be reliable, but no responsibility (or liability) is accepted for errors of fact or opinion. Writers and contributors may be trading in, or have positions in the securities mentioned in their articles. Neither I (Vikas Srivastava) nor any of the contributors accepts any liability arising out of use of the above information/article. Reproduction in whole or in part without written permission is prohibited.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.